Head-to-Head

IGC Pharma, Inc. vs. Eli Lilly & Co.

IGC

IGC Pharma, Inc.

$0.27 +1.95%

VS LLY

Eli Lilly & Co.

$1152.93 +0.04%

IGC Pharma, Inc. (IGC) comes out ahead, leading on 2 of 3 compared factors.

Size & Scale

IGCLLY
Market Cap $27.54 million $1.03 trillion
Revenue (TTM) — $79.67 billion
Net Income (TTM) — $26.71 billion

LLY leads on 1 of 1 size & scale factors.

Valuation

IGCLLY
P/E Ratio — 38.70
Price / Book 4.49 30.33
Price / Sales — 12.90

IGC leads on 1 of 1 valuation factors.

Profitability

IGCLLY
Net Margin — 33.53%
Return on Equity — 78.84%

IGC and LLY split the profitability factors evenly.

Dividend

IGCLLY
Dividend Yield — 0.60%
Payout Ratio — 23.23

IGC and LLY split the dividend factors evenly.

Risk & Sentiment

IGCLLY
Short Interest 0.59% 1.29%

IGC leads on 1 of 1 risk & sentiment factors.

Dig deeper: IGC overview, IGC financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.